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Abstract 
Infection with dengue virus (DENV) is considered as serious public health issues internationally as amounted to 
2.5 billion people are at infection risk throughout the world. Dengue is now endemic in Pakistan. Till now, no 
licensed vaccine is available against dengue virus infection. The main purpose of this study was to find out 
differences in the levels of IgM and IgG on gender basis as well as distribution of dengue serotypes in the local 
population of district Lahore, Pakistan. Fifteen blood samples including 3 control sample were collected from 
dengue infected patients and statistical results showed significantly higher mean levels of IgM (1.12 + 0.09) and 
IgG (2.07 + 0.56) antibodies in patients as compared to control groups for IgM (0.34 + 0.05) and IgG (0.10 + 
0.05) antibodies respectively. Statistical results on Gender base showed significantly higher mean levels of IgM 
(1.10 + 0.19) in males and of IgG (2.27 + 0.74) in females. The enveloped gene of 1.5 kb was successfully 
amplified through polymerase chain reaction and cloned in рTZ57R/T. The cloned gene was then confirmed 
through restriction digestion. Out of 15 dengue samples, only 3 dengue samples were successfully amplified 
using polymerase chain reaction which all belongs to serotype 2 In future, it may contribute in development of 
treatment to dengue infection with dengue virus type 2 which is more prevalent in district Lahore. 
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1. Introduction 
It is estimated that about 2.5 billion people are at the risk of dengue infection worldwide. Each year about 50 – 
100 million dengue infections occurred throughout the world. Out of them more than 1.5 million individuals 
show the clinical presentation and about 500,000 infections lead towards severe disease conditions like dengue 
hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Approximately about 25000 deaths report each 
year as a result of dengue infection, especially in children [20]. 
It is believed that dengue virus came in Pakistan in the form of infected mosquito eggs placed in tyres at Karachi 
sea port [1, 4]. Data suggested that in last 20 years about seven epidemics had been reported from Pakistan [17] 
but the outbreak appeared in 2011 was the worst outbreak in the history of Pakistan. This outbreak involved 23, 
252 laboratory confirmed cases and 361 deaths. A large number of cases reported from Punjab province but 
Sindh province was also badly affected [22]. 
Infection with dengue virus (DENV) is considered as major public health issue internationally [13]. Dengue 
viruses are belongs to family Flaviviridae [23]. “Aedes aegypti” a species of mosquito considered as principle 
vector for the transmission of dengue virus [16]. Aedes aegypti larvae usually finds at standing clean water 
reservoirs like fresh water buckets, water storage containers and discard tyres [2, 9, 14, 5]. 
Dengue virus has positive sense, single stranded RNA genome consist of 10,700 nucleotides [15]. Dengue virus 
genome encodes three structural and seven nonstructural proteins [20]. The structural proteins are named as 
capsid (C), membrane (M) and envelope (E) and non - structural proteins are named as NS1, NS2a, NS2b, NS3, 
NS4a, NS4b and NS5 [15]. Dengue virus exists as four serotypes. These four serotypes are antigenically distinct 
from each other denoted as DENV – 1, DENV – 2, DENV – 3 and DENV – 4 [7]. 
As there is no licensed vaccine available for dengue virus infection till now so a safe and effective vaccine is the 
urgently needed [21]. Till now all vaccines (in development phase) have aim to produce immunity against all 
four serotypes but there are hurdles in development of such vaccines [8]. The main purpose of this study was to 
find out differences in the levels of IgM and IgG on gender basis as well as distribution of dengue serotypes in 
the local population of district Lahore, Pakistan. 
2. Materials & Methods 
2.1. Collection of blood samples 
Blood samples (2-3 ml) were collected from dengue virus patients with the help of expert technicians and 
consent of patients. Blood samples were drawn from forearm in 5 ml sterile BD syringes using aseptic vein 
puncture technique.  
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2.2. Primers designing 
A set of serotype specific primers were designed to amplify envelope gene from serum sample of patients 
infected with dengue virus. Serotype specific forward (F) and reverse (R) primers were designed from gene 
bank sequence (Accession NO: JN030340) by using Primer 3 software (Table 1). 
Table 1: List of oligonucleotides primers used for the amplification of enveloped gene 
Primers 
Name 
Primer Sequence (5ʹ - 3ʹ) Amplified 
Product (kb) 
EDENV-1F F’:5-GGCGAATTCATGCGATGCGTGGGAAT-3 
                   EcoRI 
 
1.5 
EDENV-1R R’:5-TACTCGAGCGCCTGAACCATGACTC-3 
                 XhoI 
EDENV-2F F’:5-GCGGCAAGCTTATGCGTTGTATTGGAATA-3 
                          HindIII 
 
1.5 
EDENV-2R R’:5-TACTCGAGAGCCTGCACCATAACTCCCAAA-3 
                  XhoI 
REDENV-2F F’: 5-GCGGCAAGCTTGCTCCTTCAATGACAATG -3   
                         HindIII 
 
1.5 
REDENV-2R R’: 5-TACTCGAGGCTCACAACGCAACCACTATC-3  
                   XhoI               
EDENV-3F F’:5-GCGGTCGACATGAGATGTGTGGGAGT-3 
                    SalI 
 
1.5 
EDENV-3R R’:5-CACTCGAGATAGAGTGTGATGATTCC-3 
                  XhoI 
2.3. Screening of samples 
Samples were screened on the basis of presence of dengue virus IgM and IgG antibodies. Only dengue virus 
IgM or IgG positive samples were selected for analysis. Viral RNA was isolated from 100ul patient sera using 
Nucleospin Viral RNA isolation kit (Machery Nagel) and cDNA was synthesized using reverse transcriptase. 
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2.4. Amplification of envelope gene 
Two rounds of amplifications were carried out through Polymerase Chain Reaction (PCR); first round PCR was 
involved first set of specified primers (REDENV2) and 3μl cDNA as template. Thermal cyclic condition were: 
Initial Denaturing at 94 °C for 3 minutes, Denaturing at 94 °C for 1 minute, Annealing at 57 °C for 1 minute, 
Extension at 72 °C for 1 minute, Go to (2) Cycle 35 and Final Extension at 72 °C for 10 minutes. Second round 
Nested PCR was involved second set of specified primers (EDENV2) and first PCR product 2μl as template. 
Thermal cyclic condition were: Initial Denaturing at 94 °C for 3 minutes, Denaturing at 94 °C for 1 minute, 
Annealing at 56 °C for 1 minute, Extension at 72 °C for 1 minute, Go to (2) Cycle 35 and Final Extension at 72 
°C for 10 minutes. Dream Taq Green PCR Master Mix (2x) was used for Polymerase Chain Reaction (PCR) 
according to manufacturer’s protocol. PCR was performed in 0.2 ml PCR tubes containing 25μl total reaction 
mixture. Nuclease free water was used as PCR water.  
2.4 Construction of cloning vector 
Full length PCR amplified envelope gene (1485 bp) was then ligated to the рTZ57R/T vector (2886 bp) using 
T4 DNA ligase. After ligation, the constructed vector containing a gene of interest was named pAIQ.EDENV-2 
(Figure 1). 
2.5. Restriction analysis 
The “Heat Shock Method” was used for the transformation of competent cells (DH5 alpha), with 
pAIQ.EDENV-2.The GeneJET Plasmid Miniprep Kit was used for plasmid isolation with inserted gene and 
were confirmed through restriction digestion with HindIII and XhoI. Agarose gel of 1.5% was used to analyze 
amplified product, plasmid DNA and restriction digestion. 
2.6. Statistical analysis 
Statistical analysis was performed on data using SPSS software. The results were interpreted and finally 
presented in graphical format. 
3. Results 
3.1. Samples screening 
From 15 collected samples; 3 samples were negative control while remaining 12 samples were positive on the 
IgM and IgG basis. These positive samples were further screened through Polymerase Chain Reaction (PCR) by 
using set of specified primers for envelope gene of dengue virus type 2, 3 and 4. There were significant higher 
mean levels (1.12 + 0.09) of IgM were observed in dengue patients as compared to the control group levels 
(0.34 + 0.05) as p< 0.05. Same trend was found in IgG, where higher mean levels (2.07 + 0.56) of IgG were 
observed in dengue patients as compared to the control group levels (0.10 + 0.05) as p< 0.05 (Table 2). 
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Figure 1: Construction of pAIQ.EDENV-2; Full length envelope gene was ligated to the рTZ vector. The 
resulted construct was designated as pAIQ.EDENV-2. 
 
Table 2: Comparison of IgM and IgG in Dengue Patients and Control Group 
 
Groups N Mean 
Std. Error 
Mean p-Value 
IgM Control 3 0.34 0.05 0.002* 
Patients 12 1.12 0.09   
IgG Control 3 0.10 0.05 0.005* 
Patients 12 2.07 0.56   
                *Significant at P<0.05 
Table 3 showed significant higher mean levels (1.10 + 0.19) of IgM were observed in male as compared to the 
female levels (0.86 + 0.12). But in the case of IgG opposite trends were found, where higher mean levels (2.27 + 
0.74) of IgG were observed in female as compared to the male levels (0.99 + 0.58). 
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Table 3: Comparison of IgM and IgG on Gender Basis 
 
Gender N Mean 
Std. 
Deviation 
Std. Error 
Mean 
IgM male 7 1.10 0.52 0.19 
female 8 0.86 0.36 0.12 
IgG male 7 0.99 1.53 0.58 
female 8 2.27 2.11 0.74 
 
3.2. Amplification of envelope gene 
The envelope gene was PCR amplified by using two sets of specified primers. The amplified product were 
analyzed on 1.5% agarose gel, a targeted band of 1485bp was appeared (Figure 2). 
 
Figure 2: PCR amplified product of Envelope (E) Gene. Lane M (100 bp DNA Ladder); Lane 1 & 2 (Amplified 
envelope gene 1485 bp); Lane 3 (Negative control) 
3.3. Restriction digestion 
On digestion of recombinant plasmid (pAIQ.EDENV-2) with HindIII and XhoI restriction enzymes, two bands, 
one corresponding to рTZ57R/T vector (2886 bp) and second of envelope gene (1485 bp) were observed on 
1.5% agarose gel (Figure 3) . 
4. Discussion 
Dengue viruses (DENVs), belongs to family Flaviviridae, are responsible for dengue infections in humans [23]. 
According to estimation more than 2.5 billion people lives in areas of infection risk and each year about 25000 
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deaths are reporting due to dengue virus infection [20]. Data shows that about seven epidemics had been 
reported from Pakistan during last 20 years [17] but the outbreak of 2011was the worst outbreak with 23, 252 
laboratory confirmed cases and 361 deaths [22].  
 
Figure 3: Restriction Digestion of pAIQ.EDENV-2. Lane M (100 bp DNA Ladder); Lane 2 (Upper band 2886 
bp), (lower band1485 bp) . 
The main purpose of this study was to find out differences in the levels of IgM and IgG on gender basis and 
distribution of dengue serotypes in the population of district Lahore, Pakistan. Fifteen blood samples were 
collected from dengue infected patients and statistical results showed significantly higher mean levels of IgM 
(1.12 + 0.09) and IgG (2.07 + 0.56) antibodies in patients as compared to control groups for IgM (0.34 + 0.05) 
and IgG (0.10 + 0.05) antibodies respectively. Statistical results on Gender base showed significantly higher 
mean levels of IgM (1.10 + 0.19) in males and of IgG (2.27 + 0.74) in females. Dengue IgM capture ELISA and 
IgG ELISA are both sensitive and specific assay for the detection of antibodies [3,11]. Assay that apply antigen 
from Dengue virus type 1 through 4 have a high sensitivity and specificity, range from 90 to 100% but unable to 
discriminate four serotypes [11, 18]. 
There are four antigenically distinct DENV serotypes DEN-1, DEN-2, DEN-3 and DEN-4 [6]. Among three 
structural proteins DENV envelope protein (~ 495 amino acids) has prime importance. As a surface protein, 
envelope (E) protein not only facilitates the attachment of DENV with host cell but also plays an important role 
in virus entry to the cell [19, 12]. Envelope (E) protein contains three structural domains, Domain I, II and III 
[10]. In the past, mostly domain III was selected for amplification and cloning purposes. 
In this research work, full length envelope (E) gene of 1485 bp was amplified and cloned. The RNA was 
isolated from serum of dengue virus infected patients. PCR was performed by using set of specified primers 
(EDENV2) for dengue virus type 2. Gel electrophoresis was used to visualize the PCR product and then 
amplified product was purified. The purified product was cloned into рTZ57R/T vector to construct recombinant 
pAIQ.EDENV-2. The plasmid DNA from constructed clone was isolated and purified by restriction digestion 
with HindIII and XhoI. The results indicate the proper ligation of envelope (E) gene to pTZ vector. 
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It is suggested that further work can be planned for sub-cloning of envelope (E) gene in expression vector to 
construct fusion plasmid and transformation into competent host for bacterial expression. The antigenicity of 
expressed protein can also evaluate by using suitable animal model. There is also a hope that in future, the study 
can contribute in understanding of disease pathogenesis, development of a safe and effective vaccine, and in 
establishing novel diagnostic tools and therapeutics. 
5. Conclusion 
There were higher mean values of IgM and IgG exist for dengue virus patients as compared to the control group. 
At the same time IgM values were observed relatively high in males as compared to females while IgG values 
were observed relatively high in females as compared to male. Dengue serotype 2 is more prevalent in local 
population of Lahore district. 
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